• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: W. L. GORE & ASSOCIATES, INC. GORE® EXCLUDER® AAA ENDOPROSTHESIS; SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

W. L. GORE & ASSOCIATES, INC. GORE® EXCLUDER® AAA ENDOPROSTHESIS; SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT Back to Search Results
Model Number PLC271200
Device Problems Improper or Incorrect Procedure or Method (2017); Patient-Device Incompatibility (2682); Device-Device Incompatibility (2919); Unintended Movement (3026)
Patient Problem Aneurysm (1708)
Event Date 09/19/2022
Event Type  Injury  
Manufacturer Narrative
Concomitant medical products: gore® excluder® iliac branch endoprosthesis iliac branch component - sn (b)(4); gore® excluder® aaa endoprosthesis - sn (b)(4); gore® excluder® aaa endoprosthesis - sn (b)(4).Device remains implanted and is unavailable for manufacturer evaluation.A review of the manufacturing records indicated the lot met pre-release specifications.W.L.Gore & associates, inc.(gore) is submitting this report to comply with 21 c.F.R.Part 803, the medical device reporting regulation.This report is based upon information obtained by gore, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.This report does not constitute an admission or a conclusion by fda, gore, or its associates that the device, gore or its associates caused or contributed to the event described in the report.In particular, this report does not constitute a legal admission by anyone that the product described in this report has any defects or has malfunctioned, as defined from a legal standpoint.These words are included in the report and are fixed items for selection created by the fda, to categorize the type of event solely for the purpose of reporting pursuant to part 803.This statement should be included with any information or report disclosed to the public under the freedom of information act.
 
Event Description
It was reported that a patient was treated for a left iliac aneurysm with a gore® excluder® iliac branch endoprosthesis on (b)(6) 2022.The patient tolerated the procedure.On september 19, ct imaging appeared to show that the contralateral leg was separated from or was not placed optimally in the iliac branch component, causing a type iii endoleak.The endoprostheses are planned to be relined on (b)(6) 2022.
 
Event Description
It was reported that a patient was treated for a left iliac aneurysm with a gore® excluder® iliac branch endoprosthesis on (b)(6) 2022.The patient tolerated the procedure.On (b)(6) ct imaging appeared to show that the contralateral leg was separated from or was not placed optimally in the iliac branch component, causing a type iii endoleak.The type iii endoleak was treated with relining on (b)(6) 2022.An endoleak persisted after the reintervention.It is now thought the patient is presenting with a type ii endoleak.No further reintervention is planned.The patient tolerated the procedure.
 
Manufacturer Narrative
A review of the manufacturing records indicated the lot met pre-release specifications.Imaging provided is an arterial phase, post-implant cta.Non-con and delay phases not available.There is < 1 cm of overlap between the distal end of the contralateral limb and the proximal end of the ibe component.There is a contrast-like density present outside of the device, cannot confirm contrast without a non-contrast ct available for comparison.However, if contrast could be confirmed, this would be consistent with the reported type iii endoleak, likely due to the lack of overlap between components.There are patent lumbars present at the level of the implanted device.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GORE® EXCLUDER® AAA ENDOPROSTHESIS
Type of Device
SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT
Manufacturer (Section D)
W. L. GORE & ASSOCIATES, INC.
1505 n. fourth street
flagstaff AZ 86004
Manufacturer (Section G)
MEDICAL SILICON VALLEY B/P
2890 de la cruz blvd.
santa clara CA 95050
Manufacturer Contact
tom hormby
1505 n. fourth street
flagstaff, AZ 86004
9285263030
MDR Report Key15792532
MDR Text Key303626749
Report Number3013164176-2022-01537
Device Sequence Number1
Product Code MIH
UDI-Device Identifier00733132618545
UDI-Public00733132618545
Combination Product (y/n)N
Reporter Country CodeGM
PMA/PMN Number
P020004
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup,Followup
Report Date 05/17/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received11/14/2022
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date04/21/2024
Device Model NumberPLC271200
Device Catalogue NumberPLC271200
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received05/17/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured04/23/2021
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
SEE H10.
Patient Outcome(s) Other;
Patient SexFemale
Patient Weight65 KG
-
-